Your Messages Inbox
Your Article Summary
See Latest Articles(Click the title below to leave the MDLinx Network and go to the Journal's Website)
Merck eyes deals, growth through 2013
Corporate News Releases - The Healthcare Sales & Marketing Network, 11/20/08
Merck & Co Inc's CEO sees profit growth from 2010 to 2013 despite looming generic competition for two of its biggest drugs, and has the appetite to buy a big biotechnology company if the right deal comes along.
Today in Biotechnology...keeping you current
Receive free subspecialty "5-minute updates" via email
Safety First in Biotech Development
BioPharm, 12/03/09
Teva Announces The Submission Of A Biologics License Application (BLA) For XM02 For The Treatment Of Chemotherapy-Induced Neutropenia
Teva Pharmaceutical Industries, 12/02/09
Complete Genomics and GATC Biotech Collaborate on Human Genome Sequencing Projects
b3c newswire, 12/02/09
Article Search
Sponsor